These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 37841238

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pancreatitis and Hyperlipasemia in the Setting of Immune Checkpoint Inhibitor Therapy.
    Townsend MJ, Liu M, Giobbie-Hurder A, Sack JS, LeBoeuf NR, Hodi FS, McNabb-Baltar J, Grover S.
    J Natl Compr Canc Netw; 2023 Aug; 21(8):831-840.e3. PubMed ID: 37549912
    [Abstract] [Full Text] [Related]

  • 3. Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy - A multicentre study of 90 patients from the German Dermatooncology Group.
    Grimmelmann I, Momma M, Zimmer L, Hassel JC, Heinzerling L, Pföhler C, Loquai C, Ruini C, Utikal J, Thoms KM, Kähler KC, Eigentler T, Herbst RA, Meier F, Debus D, Berking C, Kochanek C, Ugurel S, Gutzmer R, German Dermatooncology Group (DeCOG).
    Eur J Cancer; 2021 May; 149():1-10. PubMed ID: 33812141
    [Abstract] [Full Text] [Related]

  • 4. The multifaceted nature of diabetes mellitus induced by checkpoint inhibitors.
    Marchand L, Disse E, Dalle S, Reffet S, Vouillarmet J, Fabien N, Thivolet C, Cugnet-Anceau C.
    Acta Diabetol; 2019 Dec; 56(12):1239-1245. PubMed ID: 31423559
    [Abstract] [Full Text] [Related]

  • 5. Type 3 autoimmune pancreatitis (immune checkpoint inhibitor-induced pancreatitis).
    Sayed Ahmed A, Abreo M, Thomas A, Chari ST.
    Curr Opin Gastroenterol; 2022 Sep 01; 38(5):516-520. PubMed ID: 35881977
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pancreas-specific immune-related adverse events in patients with lung cancer: a case series study.
    Jia L, Yuequan S, Jian F, Hongmin L, Yongjie S, Xiaoyan L, Minjiang C, Yan X, Mengzhao W.
    Immunotherapy; 2024 Sep 01; 16(11):715-722. PubMed ID: 38888461
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New insight in endocrine-related adverse events associated to immune checkpoint blockade.
    Elia G, Ferrari SM, Galdiero MR, Ragusa F, Paparo SR, Ruffilli I, Varricchi G, Fallahi P, Antonelli A.
    Best Pract Res Clin Endocrinol Metab; 2020 Jan 01; 34(1):101370. PubMed ID: 31983543
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immune checkpoint inhibitors-induced diabetes mellitus (review).
    Chen J, Hou X, Yang Y, Wang C, Zhou J, Miao J, Gong F, Ge F, Chen W.
    Endocrine; 2024 Nov 01; 86(2):451-458. PubMed ID: 38955861
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Endocrine Adverse Events Caused by Different Types and Different Doses of Immune Checkpoint Inhibitors in the Treatment of Solid Tumors: A Meta-Analysis and Systematic Review.
    Yang Y, Liu J, Yang K, Ma Y, Fu S, Tang X, Wang Y, Zhou L.
    J Clin Pharmacol; 2021 Mar 01; 61(3):282-297. PubMed ID: 33345342
    [Abstract] [Full Text] [Related]

  • 16. Immune Checkpoint Inhibitor-Induced (Type 3) Autoimmune Pancreatitis.
    Shirwaikar Thomas A, Chari ST.
    Curr Gastroenterol Rep; 2023 Oct 01; 25(10):255-259. PubMed ID: 37845557
    [Abstract] [Full Text] [Related]

  • 17. Immunotherapy-Associated Pancreatic Adverse Events: Current Understanding of Their Mechanism, Diagnosis, and Management.
    Liu Y, Zhang H, Zhou L, Li W, Yang L, Li W, Li K, Liu X.
    Front Oncol; 2021 Oct 01; 11():627612. PubMed ID: 33732647
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [IMMUNE CHECKPOINT INHIBITOR-INDUCED DIABETES MELLITUS].
    Fischer M, Amos S, Levy L, Pollack R.
    Harefuah; 2021 Oct 01; 160(10):657-662. PubMed ID: 34689435
    [Abstract] [Full Text] [Related]

  • 20. Endocrine toxicities of immune checkpoint inhibitors.
    Wright JJ, Powers AC, Johnson DB.
    Nat Rev Endocrinol; 2021 Jul 01; 17(7):389-399. PubMed ID: 33875857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.